Print page content Print
Increase text size Decrease text size
Text Size


Helps protect healthy cats against feline rhinotracheitis and feline respiratory disease caused by feline calicivirus


FELOCELL FVR C (IN) is for intranasal (IN) vaccination of healthy cats 12 weeks of age or older as an aid in preventing feline rhinotracheitis caused by feline herpesvirus-1 and feline respiratory disease caused by feline calicivirus (FCV). Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.

Collapse All
    • Felocell FVR C (IN) contains attenuated strains of feline herpesvirus-1 (FHV-1) and feline calicivirus (FCV) propagated on established cell lines.
    • Highly specialized vaccine allows for tailored protocols.
    • FELOCELL FVR C (IN) is supported by our Companion Animal Immunization Support Guarantee (ISG).

    General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well. Using sterile dropper, inoculate nasal passages with entire volume of vaccine. Alternatively, 1 drop of vaccine may be placed in each eye and the remainder placed into nasal passages. Administer vaccine within 30 minutes after rehydration.

    Primary Vaccination: Healthy cats 12 weeks of age or older should receive one 0.5-mL dose. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.

    Revaccination: Annual revaccination with a single dose is recommended.

WARNING: Transient sneezing may be observed 4-7 days after vaccination. Oral lesions may be observed post-vaccinally, but typically heal without incident. Vaccination of cats incubating or harboring latent infections may result in more pronounced upper respiratory signs, ocular irritation, or febrile response.

Store at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency.
Do not freeze.
Use entire contents when first opened.
Burn containers and all unused contents.
Contains gentamicin as preservative.
In case of anaphylaxis, administer epinephrine or equivalent.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

Technical inquiries should be directed to Zoetis Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).

For veterinary use only.




Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2021 Zoetis Services LLC. All rights reserved.